⌘K

Login Start Free

Home/Filings/4/0001140361-21-008343

4//SEC Filing

BALTHROP PATRICK J 4

Accession 0001140361-21-008343

CIK 0001586049other

View on SEC.gov Company Profile

Filed

Mar 11, 7:00 PM ET

Accepted

Mar 12, 4:36 PM ET

Size

19.4 KB

Accession

0001140361-21-008343

Insider Transaction Report

Form 4

Period: 2021-03-08

Oxford Immunotec Global PLCOXFD

BALTHROP PATRICK J

Director

Transactions

Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$7.51/sh−7,457$56,002→ 0 total
Exercise: $14.49Exp: 2028-06-19→ Ordinary Shares (7,457 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$9.04/sh−9,494$85,826→ 0 total
Exercise: $12.96Exp: 2030-06-24→ Ordinary Shares (9,494 underlying)
Disposition to Issuer
Ordinary Shares
2021-03-08$22.00/sh−8,081$177,782→ 0 total
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$10.38/sh−3,728$38,697→ 0 total
Exercise: $11.62Exp: 2026-01-29→ Ordinary Shares (3,728 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$10.38/sh−14,914$154,807→ 0 total
Exercise: $11.62Exp: 2026-01-29→ Ordinary Shares (14,914 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$13.35/sh−7,457$99,551→ 0 total
Exercise: $8.65Exp: 2026-06-28→ Ordinary Shares (7,457 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$7.54/sh−7,457$56,226→ 0 total
Exercise: $14.46Exp: 2027-06-06→ Ordinary Shares (7,457 underlying)
Disposition to Issuer
Stock Option (Right to Buy)
2021-03-08$7.56/sh−7,457$56,375→ 0 total
Exercise: $14.44Exp: 2029-06-18→ Ordinary Shares (7,457 underlying)

Footnotes (3)

[F1]Disposed pursuant to the acquisition by PerkinElmer (UK) Holdings Limited of the entire issued share capital of Oxford Immunotec Global PLC on March 8, 2021 by means of a scheme of arrangement under Part 26 of the Companies Act 2006 (the "Scheme").
[F2]In connection with the Scheme, all stock options were cancelled in exchange for a payment equal to $22.00 with respect to each ordinary share subject to the option award, less the applicable exercise price.
[F3]Represents the payment per ordinary share received in exchange for the cancellation of each option of $22.00, less the applicable exercise price.

Documents

1 file

4
form4.xmlPrimary
FORM 4

Issuer

Oxford Immunotec Global PLC

CIK 0001586049

Entity typeother

Related Parties

1

filerCIK 0001284839

Filing Metadata

Form type: 4
Filed: Mar 11, 7:00 PM ET
Accepted: Mar 12, 4:36 PM ET
Size: 19.4 KB

View on SEC.gov